Retention driver
Support
Not incentives or reminders
Key window
Month 1
Highest early dropout risk
Retention lift
Up to 63%
With active engagement model
Patient Retention Model
Proactive support · Early intervention
The most common retention interventions — financial incentives, automated SMS reminders, visit scheduling flexibility, and patient-facing apps — address logistical barriers to participation. They work to a point. But the most significant driver of trial dropout is not logistical. It is relational.
Patients who feel connected to a study team, who believe their participation is genuinely valued, and who have a consistent point of contact they can reach when they have questions are substantially more likely to complete long-duration trials than patients in the same protocol who receive only automated support.
The distinction matters operationally because it changes what investments produce the highest retention yield. Doubling the financial incentive rarely moves the needle. Adding a human layer that keeps the patient-study relationship active throughout the arc of participation does.
See also: Concierge-as-a-Service™ · Patient Support
Understanding why patients leave is the prerequisite for building a retention model that actually addresses the causes.
Patients who hear from their study team only at scheduled visits or when something is wrong do not develop the relational connection that sustains long-term participation. Passive study design — collect data, don't engage between windows — creates structural dropout risk.
Protocol complexity directly affects retention. Studies that require frequent visits, lengthy assessment batteries, or cumbersome home tasks experience higher dropout, particularly in populations with competing life priorities. Burden mapping at protocol design should be standard practice.
Illness, family events, job changes, and moves all create compliance breaks. Patients who miss one or two assessments without proactive re-engagement often do not return to full compliance — the break becomes permanent.
Patients experiencing side effects or worsening symptoms who do not have a clear point of contact are at high dropout risk. Studies that treat adverse event support and retention support as separate functions often fail both.
Transportation, scheduling conflicts, and reimbursement delays are addressable but commonly under-resourced. These are the easiest barriers to remove, but they are rarely the root cause when retention is measured against protocol expectations.
Long studies involve patients who are living full lives. Participation becomes background noise. Regular engagement — not just compliance reminders — maintains the salience of the study in the patient's awareness.
Effective retention is proactive, personalized, and human — not automated, generic, and reactive. The difference shows up in the data.
Related: eCOA & ePRO
Incentives help with enrollment and reduce logistical barriers. They have a more limited effect on mid-study retention. Patients who are motivated primarily by compensation are more likely to withdraw when the participation burden increases. Relational engagement produces more durable retention.
In studies under six months, the primary focus is onboarding quality and burden management. In studies over six months, relational continuity and proactive re-engagement at motivation plateaus become the dominant drivers. Long studies need active retention infrastructure, not just good initial onboarding.
eCOA compliance and retention are related but distinct. A patient can remain enrolled while not completing assessments. Active compliance monitoring that triggers early outreach when completion drops often prevents the next stage — withdrawal — by addressing the patient's issues before they make a formal dropout decision.
Delve's concierge model delivers proactive patient engagement, compliance monitoring, and human outreach that reduces mid-study dropout and protects longitudinal data quality.
Talk About Patient Retention